Exposure to Radiologic Contrast Media and an Increased Risk of Treated End-Stage Renal Disease

American Journal of the Medical Sciences

Volumn 326, Issue 6, 2003, Pages 353-359

  Muntner, Paul ^a   Coresh, Josef ^b   Klag, Michael J ^b   Whelton, Paul K ^a   Perneger, Thomas V ^c  

^a TULANE UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Chronic kidney disease; End stage renal disease; Radiocontrast media

Indexed keywords

CONTRAST MEDIUM;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BARIUM ENEMA; CASE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIALYSIS; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; INTERVIEW; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0348014647     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200312000-00011     Document Type: Article

References (23)

1. Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74: 243-8.
2. Lautin EM, Freeman NJ, Sheonfeld NJ. Radiocontrast-associated renal dysfunction: incidence and risk factors. Am J Radiol 1991;157:49-58.
3. Schwartz RD, Rubin JE, Leeming RW, et al. Renal failure following major angiography. Am J Med 1978;65:31-7.
4. Taliereo CP, Vliestra RE, Fischer LD, et al. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986;104:501-4.
5. Cornan RE. Diseases of the kidney. 5th ed. Boston: Little, Brown, and Company; 1993. p. 1187-1201.
6. Perneger TV, Braneati FL, Whelton PK, et al. Studying the causes of kidney disease in humans: a review of methodologic obstacles and possible solutions. Am J Kidney Dis 1995;25:722-31.
7. Chertow GM, Christiansen CL, Cleary PD, et al. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 1995;155:1505-11.
8. Cronin RE, Henrich WL. Toxic nephropathy. In: Brenner BM, Rector FC Jr, editors. Brenner and Rector's the kidney. 5th ed. Philadelphia: WB Saunders; 1996. p. 1680-730.
9. Perneger TV, Myers TL, Klag MJ, et al. Effectiveness of the Waksberg telephone sampling method for the selection of population controls. Am J Epidemiol 1993;138:574-84.
10. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons; 1989.
11. Aday LA, Anersen R. A framework for the study of access to medical care. Health Serv Res 1974;9:208-20.
12. Shulman N, Ford C, Hall WD, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the hypertension detection and follow-up program. Hypertension 1989;13 Suppl 1:1-80-93.
13. Mehran R, Ashby DT. Radiocontrast-induced acute renal failure: allocations and outcomes. Rev Cardiovasc Med 2001;2 Suppl 1:S9-13.
14. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36:1542-1548.
15. Lepor NE. Radiocontrast nephropathy: the dye is not cast. Rev Cardiovasc Med 2000;1:43-54.
16. Barrett BJ, Parfrey PS, Vavasour HM, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992;41:1274-9.
17. Szklo M, Nieto FJ. Understanding the lack of validity: bias. In: Epidemiology: beyond the basics. Gaithersburg (MD): Aspen Publishers; 1999. p. 125-69.
18. Perneger TV, Whelton PK, Klag MJ. Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. Arch Intern Med 1995;155:1201-8.
19. Perneger TV, Whelton PK, Klag MJ, et al. Diagnosis of hypertensive end-stage renal disease: effect of patient's race. Am J Epidemiol 1995;141:10-5.
20. Perneger TV, Brancati FL, Whelton PK, et al. End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 1994;121:912-8.
21. Brancati F, Whelton P, Randall B, et al. Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT. JAMA 1997;278:2069-74.
22. Klag M, Whelton P, Randall B, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-8.
23. Klag M, Whelton P, Randall B, et al. End-stage renal disease in African-American and white men: 16-year MRFIT findings. JAMA 1997;277:1293-8.